Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A.,…
Read More...
Read More...
